Table 3. Characteristics of patient... | American Society of Hematology

Table 3.

Characteristics of patient samples used in ex vivo cytotoxicity experiments

Patient	Sex	Age, y	Diagnosis	Subtype	Disease phase	% blasts in the blood	Cytogenetics
1	M	57	AML	M5	Relapsed	64.2	Normal
2	F	77	AML	M5	De novo	25.5	46,XX,del(7)(q22q32)[19]/46,XX[1]
3	M	80	AML	M1	De novo	96	Not done
4	M	61	AML	Not documented	De novo	53	Not documented
5	M	65	AML	Not documented	De novo	80	Not documented
6	M	79	AML	Not documented	De novo	49	Not documented
7	M	49	AML	Not documented	De novo	78	inv(16)(p13.1q22) or t(16;6)(p13.1;q22); CBEB-MYH11 FLT3-ITD⁺
8	M	66	AML	Not documented	De novo	68.8	Not documented
9	F	65	AML	M0	De novo	75.8	Normal
10	M	33	AML	M5	De novo	59.4	46,XY,t(9;11)(p21;q23)[5]

Patient	Sex	Age, y	Diagnosis	Subtype	Disease phase	% blasts in the blood	Cytogenetics
1	M	57	AML	M5	Relapsed	64.2	Normal
2	F	77	AML	M5	De novo	25.5	46,XX,del(7)(q22q32)[19]/46,XX[1]
3	M	80	AML	M1	De novo	96	Not done
4	M	61	AML	Not documented	De novo	53	Not documented
5	M	65	AML	Not documented	De novo	80	Not documented
6	M	79	AML	Not documented	De novo	49	Not documented
7	M	49	AML	Not documented	De novo	78	inv(16)(p13.1q22) or t(16;6)(p13.1;q22); CBEB-MYH11 FLT3-ITD⁺
8	M	66	AML	Not documented	De novo	68.8	Not documented
9	F	65	AML	M0	De novo	75.8	Normal
10	M	33	AML	M5	De novo	59.4	46,XY,t(9;11)(p21;q23)[5]

Available patient data for the diseased patient samples used in Figures 4 and 6.

F, female; M, male.